Gender differences in patients with anti-MDA5-positive dermatomyositis: a cohort study of 251 cases
Lu Cheng,Lingxiao Xu,Yan Xu,Fenghong Yuan,Ju Li,Min Wu,Zhanyun Da,Hua Wei,Lei Zhou,Songlou Yin,Jian Wu,Yan Lu,Dinglei Su,Zhichun Liu,Lin Liu,Longxin Ma,Xiaoyan Xu,Huijie Liu,Tianli Ren,Yinshan Zang
DOI: https://doi.org/10.1007/s10067-023-06816-0
2023-11-21
Clinical Rheumatology
Abstract:ObjectiveTo investigate the impact of sex differences on the clinical characteristics and prognosis of patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5+ DM).MethodsWe retrospectively analyzed a cohort of 251 patients with MDA5+ DM, including 71 in the male group and 180 in the female group. A multivariate logistic regression model was built to analyze independent risk factors for RPILD in each group. An ROC curve was drawn to evaluate the predictive value of independent risk factors. Kaplan‒Meier analysis was used to compare the cumulative survival rates, while the log-rank test was used to test for significant differences between the two groups.ResultsPatients in the male group had a significantly higher prevalence of heliotrope rash, V sign, severe interstitial lung disease (ILD), and rapidly progressive interstitial lung disease (RPILD) than those in the female group. Anti-Ro52 positivity, high CRP level and short disease were identified as independent risk factors for RPILD in both male and female groups by multivariate logistic regression analysis. The mortality rates of males and females were 33.8% and 22.0%, respectively, and the survival time of patients in the male group was shorter than that in the female group.ConclusionMale patients with MDA5+ DM exhibit an increased risk of RPILD, elevated mortality rates and reduced overall survival time compared to their female counterparts, and anti-Ro52 positivity may be an unfavorable prognostic factor for these patients.Key Points• The prevalence of solar rash, V sign, severe interstitial lung disease (ILD) and rapidly progressive interstitial lung disease (RPILD) in anti-MDA5-positive female patients was significantly lower than that in male patients.• Positive Anti-Ro52, high CRP level, and short course of disease were independent risk factors for RPILD in both men and women.• Female patients exhibited a lower mortality rate than male patients (22.0% vs 33.8%) and demonstrated longer survival time.
rheumatology